跳至主要内容
临床试验/NL-OMON44746
NL-OMON44746招募中不适用

ENdometrial cancer SURvivors' follow-up carE (ENSURE): Less is more? Randomized controlled trial to evaluate patient satisfaction and cost-effectiveness of a reduced follow-up schedule - ENSURE

niversiteit van Tilburg0 个研究点目标入组 282 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
282

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patients with Endometrioïd type endometrial carcinoma with stage 1 (FIGO, 2009) disease, with the following combination of stage, age and grade:
  • - Stage 1A, any age, grade 1 or 2;
  • - Stage 1B, < 60 years, grade 1 or 2 without LVS
  • 2. Written informed consent
  • 3. Sufficiënt oral and written command of the Dutch language

排除标准

  • 1. Any other stage and type of endometrial carcinoma
  • 2. Histological types papillary serous carcinoma or clear cell carcinoma
  • 3. Uterine sarcoma (including carcinosarcoma)
  • 4. Radiotherapy for current endometrial carcinoma
  • 5. Previous malignancy (except for non-melanomatous skin cancer) < 5 yrs
  • 6. Confirmed Lynch syndrome
  • 7. Previous pelvic radiotherapy

研究者

发起方
niversiteit van Tilburg

相似试验